Google is licensing its diabetic retinopathy AI model to healthcare providers and healthtech partners, including Forus Health, Aurolab, and Perceptra, to broaden the tool’s reach across India and Thailand, with the goal of improving outcomes for diabetic patients.

These partners will focus on securing local regulatory approvals to integrate the model into clinical care systems in both countries. Over the next decade, they aim to provide a combined 6 million AI-supported screenings to resource-constrained communities, free of charge for patients.

Additionally, the tech giant is collaborating with the Thai Ministry of Public Health’s Department of Medical Services, which oversees the country’s diabetic retinopathy screening programme, on implementation research and cost-effectiveness analysis.